Seroatlas · Human Serome Atlas

BLNK

B-cell linker protein

Also known as: BASH, bca, BLNK_HUMAN, BLNK-s, Ly57, SLP-65, SLP65

Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession
Q8WV28
Gene
BLNK
Ensembl
ENSG00000095585
Chromosome
10
Canonical length
456 aa
Protein class
Disease related genes, Human disease related genes, Predicted intracellular proteins
Subcellular location
Vesicles,Plasma membrane

OverviewNCBI Gene

This gene encodes a cytoplasmic linker or adaptor protein that plays a critical role in B cell development. This protein bridges B cell receptor-associated kinase activation with downstream signaling pathways, thereby affecting various biological functions. The phosphorylation of five tyrosine residues is necessary for this protein to nucleate distinct signaling effectors following B cell receptor activation. Mutations in this gene cause hypoglobulinemia and absent B cells, a disease in which the pro- to pre-B-cell transition is developmentally blocked. Deficiency in this protein has also been shown in some cases of pre-B acute lymphoblastic leukemia. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, May 2012]

Canonical amino-acid sequenceUniProt

456 residues, UniProt reviewed canonical sequence.

>Q8WV28|BLNK
     1  MDKLNKITVP ASQKLRQLQK MVHDIKNNEG GIMNKIKKLK VKAPPSVPRR DYASESPADE
    61  EEQWSDDFDS DYENPDEHSD SEMYVMPAEE NADDSYEPPP VEQETRPVHP ALPFARGEYI
   121  DNRSSQRHSP PFSKTLPSKP SWPSEKARLT STLPALTALQ KPQVPPKPKG LLEDEADYVV
   181  PVEDNDENYI HPTESSSPPP EKAPMVNRST KPNSSTPASP PGTASGRNSG AWETKSPPPA
   241  APSPLPRAGK KPTTPLKTTP VASQQNASSV CEEKPIPAER HRGSSHRQEA VQSPVFPPAQ
   301  KQIHQKPIPL PRFTEGGNPT VDGPLPSFSS NSTISEQEAG VLCKPWYAGA CDRKSAEEAL
   361  HRSNKDGSFL IRKSSGHDSK QPYTLVVFFN KRVYNIPVRF IEATKQYALG RKKNGEEYFG
   421  SVAEIIRNHQ HSPLVLIDSQ NNTKDSTRLK YAVKVS

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against BLNK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability
Cell surface
Secreted
No
Transmembrane segments
0
Mean surface accessibility (rSASA)
0.6
Highest tissue expression
53 nTPM

Expression across tissuesHPA

Tissue

  • spleen: 53 nTPM
  • tonsil: 42 nTPM
  • esophagus: 39 nTPM
  • liver: 38 nTPM
  • lymph node: 33 nTPM
  • small intestine: 26 nTPM

Single-cell type

  • microglia: 703 nCPM
  • esophageal apical cells: 671 nCPM
  • pdcs: 330 nCPM
  • distal convoluted tubule cells: 302 nCPM
  • renal connecting tubule cells: 261 nCPM
  • ocular epithelial cells: 249 nCPM

Immune cell

  • plasmacytoid DC: 159 nTPM
  • memory B-cell: 111 nTPM
  • naive B-cell: 95 nTPM
  • myeloid DC: 13 nTPM
  • total PBMC: 5.5 nTPM
  • NK-cell: 1.6 nTPM

Brain region

  • choroid plexus: 34 nTPM
  • thalamus: 21 nTPM
  • hypothalamus: 21 nTPM
  • medulla oblongata: 21 nTPM
  • white matter: 21 nTPM
  • pons: 20 nTPM

DiseaseUniProt · ClinVar · IEDB · PubMed

Four sources answering four different questions about BLNK.

Disease | AllUniProt

Conditions BLNK is implicated in, by any mechanism.

Disease | GeneticClinVar

16 pathogenic / likely-pathogenic of 409 ClinVar records.

Conditions with pathogenic or likely-pathogenic variants.

Genetic constraint and essentialitygnomAD · DepMap

Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.

gnomAD LOEUF (loss-of-function intolerance)
0.39
gnomAD pLI
0.61
gnomAD missense Z
1.5
DepMap mean gene effect
0.02
DepMap dependency class
selective

Cancer expressionTCGA

Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).

OntologyGO

Biological processes

Molecular functions

Cellular components

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

InteractionsUniProt · HPA

Protein binding partners of BLNK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads BLNK as an antibody target. Whether an autoantibody or antibody against BLNK could matter depends on whether native BLNK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

BLNK is annotated at the cell surface, where native BLNK is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.

Annotation status

The present source text does not explicitly label BLNK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Canonical record: https://seroatlas.com/gene/BLNK. Study-independent annotations aggregated from UniProt, Human Protein Atlas, PubMed, IEDB, Pfam, InterPro, Gene Ontology, AlphaFold, gnomAD, DepMap, ClinVar, TCGA. Catalog release seroatlas-reviewed-human-uniprot-20260313.

Seroatlas is the reference for exploring autoantibody and antibody serology at the human-protein level: the autoreactome and human serome, multiplex serology (HuProt, HuScan, VirScan, PhIP-Seq).

Loading the interactive Seroatlas protein explorer...